Increased hypoxia-inducible factor 1α expression in lung cells of horses with recurrent airway obstruction.
Authors: Toussaint Marie, Fievez Laurence, Desmet Christophe J, Pirottin Dimitri, Farnir Frédéric, Bureau Fabrice, Lekeux Pierre
Journal: BMC veterinary research
Summary
# Editorial Summary: Hypoxia-Inducible Factor 1α in Equine Recurrent Airway Obstruction Recurrent airway obstruction (RAO, or heaves) remains poorly understood at the molecular level, despite being a common inflammatory condition triggered by organic dust exposure in susceptible horses; this research examined whether hypoxia-inducible factor 1α (HIF1α)—a cellular regulator traditionally associated with metabolic adaptation—might also drive the pathological immune responses underlying RAO. The authors investigated HIF1α expression specifically in myeloid cells (innate immune cells) isolated from affected horses' lungs, comparing these with healthy controls and examining how the condition influences this regulatory pathway. Results demonstrated significantly elevated HIF1α expression in lung cells from RAO-affected horses, suggesting this transcription factor plays an active role in sustaining the inflammatory cascade characteristic of heaves rather than being merely a bystander response to tissue hypoxia. This finding opens a new mechanistic perspective on RAO: rather than inflammation being driven solely by classical immune pathways, the metabolic-immune regulatory function of HIF1α may be critical to disease persistence, potentially offering fresh targets for therapeutic intervention beyond conventional anti-inflammatory approaches. For practitioners, these insights suggest that future RAO treatments might benefit from targeting HIF1α activity in immune cells, though further work is needed to translate this molecular discovery into clinical management strategies.
Read the full abstract on PubMed
Practical Takeaways
- •Understanding Hif1α's role in RAO may lead to novel therapeutic targets for managing heaves, potentially beyond current dust avoidance and anti-inflammatory strategies
- •This finding connects cellular hypoxia and immune dysregulation in RAO, suggesting that improving airway oxygenation and reducing inflammatory hypoxia may be mechanistically important
- •Future treatments targeting Hif1α pathways could represent a new approach to controlling the persistent airway inflammation characteristic of RAO
Key Findings
- •Hypoxia-inducible factor 1α (Hif1α) expression is increased in lung cells of horses with recurrent airway obstruction
- •Hif1α functions as an essential regulator of innate immune responses in addition to its known role in energy homeostasis and cellular adaptation to hypoxia
- •Myeloid cells appear to be key targets for Hif1α involvement in RAO pathogenesis